Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alí Duarte‐García"'
Publikováno v:
Mayo Clinic Proceedings. 96:2905-2910
Publikováno v:
Mayo Clinic Proceedings. 96:1309-1314
Autor:
Wendy M. Smith, Andrew J. Barkmeier, Thomas J. O'Byrne, Mehmet Hocaoglu, Jesse Y Dabit, Cynthia S. Crowson, Kevin G. Moder, Alí Duarte-García
Publikováno v:
Rheumatology (Oxford)
Objectives We aimed to estimate the risk of HCQ retinopathy and its risk factors among incident users in the community. Methods Using the Rochester Epidemiology Project, a record-linkage system, a cohort of incident users of HCQ was identified from 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330c9eca70b4baa91b6cf27bdaa03eb7
https://europepmc.org/articles/PMC9348760/
https://europepmc.org/articles/PMC9348760/
Autor:
Maria Margarida Cunha, Gabriela Schmajuk, Rebecca Hasseli, Namrata Singh, Tiffany Y.T. Hsu, Milena A. Gianfrancesco, Anja Strangfeld, Ranjeny Thomas, Naomi J Patel, Thierry Thomas, Philippe Dieudé, Kimme L. Hyrich, Emily Sirotich, Laura Trupin, Liselotte Tidblad, Jinoos Yazdany, René Marc Flipo, Licia Maria Henrique da Mota, Andrea M Seet, Samar Al Emadi, Carolina A. Isnardi, Saskia Lawson-Tovey, Alí Duarte-García, Hendrik Schulze-Koops, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Philip Robinson, Lindsay Jacobsohn, Elsa F Mateus, Pedro Machado, Ana Paula Monteiro Gomides, Jean W. Liew, Guillermo A. Berbotto, Miguel Bernardes, Patricia P. Katz, Martin Schäfer, Guillermo J. Pons-Estel, Ulf Müller-Ladner, Jeffrey A. Sparks, Elena Nikiphorou, Christof Specker, Paul Sufka, Zara Izadi, Loreto Carmona, Stephanie Rush, Sandra Lúcia Euzébio Ribeiro, Maria O Valenzuela-Almada, Kristin M. D’Silva, Emily L Gilbert, Raphaèle Seror, Laure Gossec, Beth I Wallace, Viviane Angelina de Souza, Akpabio Akpabio, Jérôme Avouac, Leanna Wise, Wendy Costello, Zachary S. Wallace, Suleman Bhana, Jonathan S. Hausmann, Lianne Kearsley-Fleet, Bernd Raffeiner, Carlo Alberto Scirè, Rebecca Grainger
Publikováno v:
Annals of the Rheumatic Diseases
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
ObjectiveTo investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).MethodsWe analysed the COVID-19 Global Rheumatology Alliance physician reg
Autor:
Eric L. Matteson, Kevin G. Moder, Cynthia S. Crowson, Shreyasee Amin, Kenneth J. Warrington, Alí Duarte-García, Rajiv K. Pruthi, Michael M. Pham
Publikováno v:
Arthritis & Rheumatology. 71:1545-1552
Objective To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS). Methods An inception cohort of patients with incident APS in 2000-2015 from a geographically well-defined populat
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.)References. 73(11)
OBJECTIVE Payments from the pharmaceutical industry to practicing physicians may influence prescribing behavior. This study was undertaken to investigate the nature, quantity, and geographic distribution of payments to US rheumatologists. METHODS Gen
Autor:
M. Hassan Murad, Cynthia S. Crowson, Elena Myasoedova, Kenneth J. Warrington, Alí Duarte-García, Paras Karmacharya, Mehmet Hocaoglu
Publikováno v:
Autoimmunity reviews. 19(12)
Objective Omega-3 fatty acids may decrease systemic lupus erythematosus (SLE) disease activity, however randomized controlled trials (RCT) have been small with conflicting findings. We conducted a systematic review and meta-analysis to estimate the e
Autor:
Ryan C. Ungaro, Therapy Psoriasis Patient Registry for Outcomes, Leanna Wise, Hanns-Martin Lorenz, Pascal Claudepierre, Suleman Bhana, Michael D. Kappelman, Anja Strangfeld, Loreto Carmona, Wendy Costello, Eva Klingberg, Elsa F Mateus, Pedro Machado, Rosana Quintana, Jeffrey A. Sparks, Mark Yates, Zara Izadi, Erica J. Brenner, Nick Dand, Jean W. Liew, Bimba F. Hoyer, Gabriela Schmajuk, Alí Duarte-García, Carolina A. Isnardi, Saskia Lawson-Tovey, Kristin M. D’Silva, Patricia P. Katz, Manasi Agrawal, Jinoos Yazdany, Philippe Goupille, Zenas Z N Yiu, Zachary S. Wallace, Enrique R. Soriano, Catherine H. Smith, Ana Rita Cruz-Machado, Emily L Gilbert, Naomi J Patel, Maria O Valenzuela-Almada, Jonathan S. Hausmann, Christopher E.M. Griffiths, Giovanna Cuomo, Emily Sirotich, Stephanie Rush, Laura Trupin, Ana Carolina Mazeda Pereira, Xian Zhang, Kimme L. Hyrich, Jean-Frederic Colombel, René-Marc Flipo, Rebecca Hasseli, Alain Cantagrel, Satveer K. Mahil, Marta Caprioli, Andrea M Seet, Samar Al Emadi, Philip Robinson, Claudia Diniz Lopes Marques, Ricardo Machado Xavier, Rebecca Grainger, Tiffany Y-T Hsu, Lindsay Jacobsohn, Adriana Maria Kakehasi, Paul Sufka, Milena A. Gianfrancesco, Alexander Pfeil, Jonathan Barker
Publikováno v:
JAMA Network Open
Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect), Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) & COVID-19 Global Rheumatology Alliance 2021, ' Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 ', JAMA Network Open, vol. 4, no. 10, e2129639 . https://doi.org/10.1001/jamanetworkopen.2021.29639
JAMA network open. American Medical Association
Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect), Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) & COVID-19 Global Rheumatology Alliance 2021, ' Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 ', JAMA Network Open, vol. 4, no. 10, e2129639 . https://doi.org/10.1001/jamanetworkopen.2021.29639
JAMA network open. American Medical Association
Key Points Question Is receipt of tumor necrosis factor (TNF) inhibitor monotherapy at the time of COVID-19 diagnosis associated with adverse COVID-19 outcomes compared with other treatment regimens among patients with immune-mediated inflammatory di
Autor:
Carlos A. Núñez-Álvarez, Alí Duarte-García, Alba Cicero-Casarrubias, Luis Llorente, Jorge Sanchez-Guerrero, Juanita Romero-Diaz, Sandra Juárez, Hilda Fragoso-Loyo
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196487 (2018)
PLoS ONE
PLoS ONE
Objective To determine if cognitive dysfunction in patients with systemic lupus erythematosus (SLE) derives from an inflammatory process with continuing disease activity, and increased levels of autoantibodies and inflammatory molecules in serum and
Objective.To determine whether there is any seasonal variation in the activity of systemic lupus erythematosus (SLE) overall and by individual organs.Methods.The study group comprised 2102 patients with SLE who were followed in a prospective longitud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415692695363f68de5c859d730a14e72
https://europepmc.org/articles/PMC3597113/
https://europepmc.org/articles/PMC3597113/